$XLRN ACCELERON PHARMA INC Insider Trading Week 11/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC in week 11/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.08 | 800 | 4,064 | 25,496 | |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 20,000 | |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 41.21 | 200 | 8,242 | 16,500 | 16.7 K to 16.5 K (-1.20 %) |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 41.60 | 100 | 4,160 | 16,700 | 16.8 K to 16.7 K (-0.60 %) |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 41.13 | 900 | 37,017 | 16,800 | 17.7 K to 16.8 K (-5.08 %) |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 41.21 | 800 | 32,968 | 20,004 | 20.8 K to 20 K (-3.85 %) |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.08 | 800 | 4,064 | 20,804 | 20 K to 20.8 K (+4.00 %) |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 41.63 | 721 | 30,015 | 20,004 | 20.7 K to 20 K (-3.48 %) |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 41.07 | 3,279 | 134,669 | 20,725 | 24 K to 20.7 K (-13.66 %) |
| Mar 20 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 24,004 | 20 K to 24 K (+20.00 %) |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.88 | 4,039 | 23,749 | 20,961 | |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.88 | 1,461 | 8,591 | 0 | |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.08 | 4,000 | 20,320 | 0 | |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 41.20 | 220 | 9,064 | 15,000 | 15.2 K to 15 K (-1.45 %) |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 40.67 | 5,280 | 214,738 | 15,220 | 20.5 K to 15.2 K (-25.76 %) |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.88 | 4,039 | 23,749 | 20,500 | 16.5 K to 20.5 K (+24.54 %) |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.88 | 1,461 | 8,591 | 16,461 | 15 K to 16.5 K (+9.74 %) |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 42.05 | 800 | 33,640 | 15,000 | 15.8 K to 15 K (-5.06 %) |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 41.28 | 3,200 | 132,096 | 15,800 | 19 K to 15.8 K (-16.84 %) |
| Mar 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.08 | 4,000 | 20,320 | 19,000 | 15 K to 19 K (+26.67 %) |